AC
CRXT

Ayrton Capital’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Ayrton Capital’s Portfolio CRXT Stock Details CRXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-32,525
Closed -$12K – 126
2022
Q2 		$12K Buy
+32,525
New +$12K 0.02% 81